ArticleThe pharmacogenomics journal2024

Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance).

Jai N Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.